This should allow it an opportunity to enhance profitability, as the combined sourcing entity will be able to garner greater pricing discounts from generic manufacturers. (themaven.net)
Pay - for - delay («PFD») agreements are agreements that are intended to delay the market entry of generic manufacturers with generic drugs in exchange for payments made by original pharmaceutical producers (i.e., holders of patents for an original branded drug). (europeanlawblog.eu)
But Gilead's latest agreement with the Medicines Patent Pool aims to have new drugs ready for generic manufacturers as soon as they are available in high - income countries. (newscientist.com)